Patents-Review.com
ClassID:

21136 ⎘

A61K39/29 - CPC Classification

Classification description:

Medicinal preparations containing antigens or antibodies; Viral antigens Hepatitis virus

Sub-classes:
Recent Application in this class:
#1
20260015593
2026-01-15

VSV VECTOR-ENCODED HCV ENVELOPE PROTEINS E1/E2 AS VACCINES AGAINST HEPATITIS C VIRUS

 #2
20260014251
2026-01-15

COMPOSITIONS, METHODS, AND USES FOR POLYNUCLEOTIDE FORMULATIONS FOR DRYING AND PROLONGED STORAGE

 #3
20250354172
2025-11-20

Adenoviral Vectors Comprising Partial Deletions of E3

 #4
20250339513
2025-11-06

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #5
20250339512
2025-11-06

SELF-CLEAVING POLYPROTEINS AND USES THEREOF

 #6
20250295761
2025-09-25

METHODS FOR PREVENTING DENGUE AND HEPATITIS A

 #7
20250281593
2025-09-11

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

 #8
20250215048
2025-07-03

ASSEMBLED GLYCOPROTEINS

 #9
20250213677
2025-07-03

DRUG-DELIVERY COMPOSITION INCLUDING PLANT-DERIVED NANOVESICLES AS ACTIVE INGREDIENTS

 #10
20250195635
2025-06-19

SALMONELLA FREE EGG PRODUCTION METHODS AND SYSTEMS

 #11
20250170234
2025-05-29

HEPATITIS A VIRUS PREPARATION METHOD AND HEPATITIS A VIRUS PREPARED ACCORDING TO METHOD

 #12
20250154204
2025-05-15

NOVEL REOVIRUS-BASED VACCINE PLATFORM AND USE THEREOF

 #13
20250136643
2025-05-01

HEPATITIS C VIRUS E1/E2 HETERODIMERS AND METHODS OF PRODUCING SAME

 #14
20250032606
2025-01-30

POLYVALENT VACCINES AND METHODS FOR MAKING THEM

 #15
20250018026
2025-01-16

NASAL VACCINE-SPRAYING FORMULATION FOR SIMULTANEOUSLY TARGETING NASAL MUCOSA AND NASOPHARYNX

 #16
20240398938
2024-12-05

Hepatitis C Virus Peptide Compositions and Methods of Use Thereof

 #17
20240398719
2024-12-05

CHOLESTOSOME VESICLES FOR INCORPORATION OF MOLECULES INTO CHYLOMICRONS

 #18
20240358821
2024-10-31

P7 Containing Nucleoside-modified mRNA-lipid Nanoparticle Lineage Vaccine for Hepatitis C Virus

 #19
20240335531
2024-10-10

MULTI-ANTIGEN THERAPEUTIC VACCINES TO TREAT OR PREVENT CHRONIC HEPATITIS B VIRUS INFECTION

 #20
20240316186
2024-09-26

E1E2 HCV VACCINES AND METHODS OF USE

 #21
20240301364
2024-09-12

Compositions and Methods for Antigen Targeting to CD180

 #22
20240252623
2024-08-01

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #23
20240238413
2024-07-18

HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND METHODS OF USE THEREOF

 #24
20240189421
2024-06-13

IMMUNOGENIC COMPOSITIONS OF HEPATITIS C VIRUS AND USES THEREOF

 #25
20240181043
2024-06-06

IDENTIFYING PATIENT POPULATIONS VULNERABLE TO VIRAL INFECTION AND METHODS OF INDUCING HETEROLOGOUS IMMUNITY IN SAME

 #26
20240123050
2024-04-18

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

 #27
20240100154
2024-03-28

COMPOSITIONS AND METHODS FOR PRODUCING GLYCO-MODIFIED VIRAL ANTIGENS

 #28
20240058438
2024-02-22

Hepatitis C virus immunogenic compositions and methods of use thereof

 #29
20240043509
2024-02-08

Biological Therapeutics for Infection-Relating Disorders or Conditions

 #30
20240016923
2024-01-18

MODIFIED SECRETED HEPATITIS C VIRUS (HCV) E1E2 GLYCOPROTEINS AND METHODS OF USE THEREOF

 #31
20230340085
2023-10-26

LENTIVIRAL VECTOR EXPRESSING MEMBRANE-ANCHORED OR SECRETED ANTIBODY

 #32
20230330220
2023-10-19

METHOD FOR IMPROVING IMMUNOGENICITY OF PROTEIN/PEPTIDE ANTIGEN

 #33
20230330218
2023-10-19

HEPATITIS C VIRUS MODIFIED E2 GLYCOPROTEIN AND USES THEREOF AS VACCINES

 #34
20230310590
2023-10-05

Hepatitis C virus immunogenic compositions and methods of use thereof

 #35
20230304042
2023-09-28

Adenoviral Vectors Comprising Partial Deletions of E3

 #36
20230277471
2023-09-07

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

 #37
20230218752
2023-07-13

POLYMERIC NANOPARTICLES AS VACCINE ADJUVANTS

 #38
20230181726
2023-06-15

A HEPATITIS C NUCLEIC ACID VACCINE COMPRISING A VARIABLE DOMAIN DELETED E2 POLYPEPTIDE

 #39
20230181718
2023-06-15

METHODS AND COMPOSITIONS RELATED TO VIRAL VACCINES WITH IMPROVED PROPERTIES

 #40
20230149538
2023-05-18

Methods for preventing dengue and hepatitis a

 #41
20230113073
2023-04-13

Compositions and methods for antigen targeting to CD180

 #42
20230098265
2023-03-30

E1E2 HCV VACCINES AND METHODS OF USE

 #43
20230083448
2023-03-16

COMPOSITIONS OF ALUM NANOPARTICLES FOR IMMUNOMODULATION AND METHODS FOR PRODUCING THE SAME

 #44
20230079898
2023-03-16

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HEPATITIS B AND D

 #45
20230076371
2023-03-09

PHARMACEUTICAL COMPOSITION AND USE THEREOF

 #46
20230073321
2023-03-09

PHARMACEUTICAL COMPOSITION AND USE THEREOF

 #47
20230040021
2023-02-09

IMMUNOSTIMULATORY COMPOSITION AND USE THEREOF

 #48
20230034467
2023-02-02

Engineered HCV E2 Immunogens and Related Vaccine Compositions

 #49
20230031287
2023-02-02

METHOD AND COMPOSITION FOR ENHANCING THE IMMUNE RESPONSE

 #50
20220401554
2022-12-22

USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES

 #51
20220347295
2022-11-03

Vaccine delivery method

 #52
20220305114
2022-09-29

COMBINATION OF HEPATITIS B VIRUS (HBV) VACCINES AND SMALL MOLECULE PDL1 OR PD1 INHIBITOR

 #53
20220283161
2022-09-08

METHODS AND COMPOSITIONS FOR HEPATITIS C VIRUS (HCV)

 #54
20220280440
2022-09-08

METHOD FOR THE MANUFACTURE OF A DOSAGE FORM WITH MUCOADHESIVE PROPERTIES FOR BUCCAL ADMINISTRATION OF BIOLOGICS

 #55
20220265817
2022-08-25

THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B

 #56
20220175912
2022-06-09

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use

 #57
20220168409
2022-06-02

Vaccines

 #58
20220118083
2022-04-21

Triple live vaccine of canine distemper virus, canine parvovirus and canine infectious hepatitis virus

 #59
20220118082
2022-04-21

Compositions and methods for generating an immune response to hepatitis B virus

 #60
20220105175
2022-04-07

Hepatitis C virus immunogenic compositions and methods of use thereof

 #61
20220054631
2022-02-24

MHC Class I Associated Hepatitis B Peptides

 #62
20220054630
2022-02-24

MODIFIED HEPATITIS C VIRUS E2 GLYCOPROTEINS AND METHODS OF USE THEREOF

 #63
20220041661
2022-02-10

Hepatitis c virus E1/E2 heterodimers and methods of producing same

 #64
20220040116
2022-02-10

Methods of treatment using cholestosome vesicles for incorporation of molecules into chylomicrons

 #65
20220016233
2022-01-20

Identifying patient populations vulnerable to viral infection and methods of inducing heterologous immunity in same

 #66
20210369839
2021-12-02

Microneedle system for applying a hepatitis vaccine

 #67
20210338678
2021-11-04

BIOACTIVE VITAMIN COMBINATIONS

 #68
20210308258
2021-10-07

MICROCAPSULE-BASED VACCINE

 #69
20210236626
2021-08-05

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines contaning hepatitis B virus genes

 #70
20210213129
2021-07-15

NON-PSYCHOACTIVE CANNABINOIDS AS ADJUVANTS TO ENHANCE MUCOSAL IMMUNITY

 #71
20210187101
2021-06-24

Hepatitis B vaccine transnasal administration system

 #72
20210177952
2021-06-17

METHOD AND COMPOSITION FOR STIMULATING IMMUNE RESPONSE

 #73
20210170018
2021-06-10

Hepatitis C virus immunogenic compositions and methods of use thereof

 #74
20210145963
2021-05-20

E1E2 HCV VACCINES AND METHODS OF USE

 #75
20210138063
2021-05-13

HCV vaccines

 #76
20210100895
2021-04-08

Hepatitis C virus immunogenic compositions and methods of use thereof

 #77
20210095280
2021-04-01

Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines

 #78
20210052721
2021-02-25

Hepatitis C virus peptide compositions and methods of use thereof

 #79
20210024585
2021-01-28

Engineered HCV E2 immunogens and related vaccine compositions

 #80
20210023204
2021-01-28

Methods for preventing dengue and hepatitis A

 #81
20210015916
2021-01-21

Vaccine delivery method

 #82
20210010029
2021-01-14

Adenoviral vectors comprising partial deletions of E3

 #83
20210008196
2021-01-14

Duck hepatitis A virus type 3 mutant CH-P60-117C and construction thereof

 #84
20200392083
2020-12-17

Compound having PD-L1 inhibitory activity, preparation method therefor and use thereof

 #85
20200390875
2020-12-17

Dried composition of saponin in a liposomal formulation with a neutral lipid, a sterol, and a cryoprotectant

 #86
20200282048
2020-09-10

Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

 #87
20200222528
2020-07-16

Nucleoside-modified mRNA-lipid nanoparticle lineage vaccine for hepatitis C virus

 #88
20200216819
2020-07-09

Compositions and methods for antigen targeting to CD180

 #89
20200188504
2020-06-18

Hepatitis C virus gene sequences and methods of use therefor

 #90
20200171143
2020-06-04

Virus-like particles comprising zika antigen

 #91
20200164061
2020-05-28

Poxviral vaccines

 #92
20200093915
2020-03-26

Vaccine Containing Virus-Like Particles

 #93
20200085943
2020-03-19

Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen

 #94
20200085926
2020-03-19

Antigen fused with porcine Fc fragment and vaccine composition comprising the same

 #95
20200069598
2020-03-05

Cholestosome vesicles for incorporation of molecules into chylomicrons

 #96
20190360000
2019-11-28

Adenoviral vectors comprising partial deletions of E3

 #97
20190338014
2019-11-07

Fusion peptides with antigens linked to short fragments of invariant chain(CD74)

 #98
20190284230
2019-09-19

Method for preparing multimeric forms of the hepatitis c virus (HCV) envelope glycoprotein 2 (HCV E2)

 #99
20190270792
2019-09-05

Biological therapeutics for infection-relating disorders or conditions

 #100
20190247494
2019-08-15

Polypeptide carrier for presenting target polypeptide and uses thereof

 #101
20190231867
2019-08-01

Hepatitis C virus immunogenic compositions and methods of use thereof

 #102
20190224308
2019-07-25

Hepatitis C virus immunogenic compositions and methods of use thereof

 #103
20190216921
2019-07-18

Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg

 #104
20190209677
2019-07-11

Hepatitis c virus immunogenic compositions and methods of use thereof

 #105
20190209672
2019-07-11

Hybrid hepadnavirus cores carrying multiple malaria parasite epitopes

 #106
20190201515
2019-07-04

Vaccines

 #107
20190184009
2019-06-20

Compositions and methods for generating an immune response to hepatitis B virus

 #108
20190175714
2019-06-13

Prime target

 #109
20190160166
2019-05-30

Lentiviral vectors for expression of hepatitis B virus (HBV) antigens

 #110
20190151442
2019-05-23

HEV vaccine

 #111
20190144834
2019-05-16

Compositions and methods for antigen targeting to CD180

 #112
20190134191
2019-05-09

Alhydrogel-sodium chloride compound immunologic adjuvant, preparation method and use thereof

 #113
20190125862
2019-05-02

Method for producing virus like particles

 #114
20190083608
2019-03-21

Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine

 #115
20190083607
2019-03-21

Chimeric hepatitis D virus antigen and hepatitis B virus pre S1 genes for use alone or in vaccines containing hepatitis B virus genes

 #116
20190038740
2019-02-07

MHC class I associated hepatitis B peptides

 #117
20180371064
2018-12-27

Lentiviral vector expressing membrane-anchored or secreted antibody

 #118
20180360939
2018-12-20

Dried saponin liposomal composition

 #119
20180311339
2018-11-01

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #120
20180311326
2018-11-01

IMMUNOASSEMBLIN (IA) PROTEIN COMPLEXES

 #121
20180282407
2018-10-04

INHIBITOR OF HEPATITIS C VIRUS INFECTION

 #122
20180282377
2018-10-04

Hepatitis C virus E1/E2 heterodimers and methods of producing same

 #123
20180256633
2018-09-13

LONG CHAIN INULIN FOR STIMULATING AN IMMUNE RESPONSE

 #124
20180169219
2018-06-21

Hepatitis C virus immunogenic compositions and methods of use thereof

 #125
20180140699
2018-05-24

Methods for preparing hepatitis B immunoglobulin derived from plasma

 #126
20180136211
2018-05-17

METHODS AND DEVICES FOR DETECTING HEPATITIS C VIRUS

 #127
20180125968
2018-05-10

Poxviral vaccines

 #128
20180085313
2018-03-29

Thermostable vaccines based on ether lipids and native viral envelope proteins

 #129
20180064805
2018-03-08

Method of Vaccination Comprising a Histone Deacetylase Inhibitor

 #130
20180055780
2018-03-01

Cholestosome vesicles for incorporation of molecules into chylomicrons

 #131
20180015156
2018-01-18

POLYMER PARTICLES AND USES THEREOF

 #132
20170360847
2017-12-21

Cyclic di-AMP induction of type I interferon

 #133
20170335345
2017-11-23

Pharmaceutical composition for treatment and/or prevention of hepatitis C

 #134
20170333550
2017-11-23

Poxviral vaccines

 #135
20170326231
2017-11-16

Epitope of hepatitis B virus surface antigen and binding molecule specifically binding to same for neutralizing hepatitis B virus

 #136
20170274067
2017-09-28

Development of methods for production of a whole virus vaccine candidate stock and novel adaptive mutations in hepatitis C virus

 #137
20170224811
2017-08-10

Vaccine adjuvant compositions

 #138
20170224806
2017-08-10

RECOMBINANT BACTERIUM AND METHODS OF ANTIGEN AND NUCLEIC ACID DELIVERY

 #139
20170218393
2017-08-03

EXPRESSION SYSTEM FOR MODULATING AN IMMUNE RESPONSE

 #140
20170216573
2017-08-03

INJECTION NEEDLE AND DEVICE

 #141
20170202958
2017-07-20

VACCINE DELIVERY METHOD

 #142
20170196970
2017-07-13

Adjuvant for mucosal vaccine

 #143
20170190737
2017-07-06

Macrocyclic inhibitors of flaviviridae viruses

 #144
20170190734
2017-07-06

Macrocyclic inhibitors of flaviviridae viruses

 #145
20170182153
2017-06-29

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

 #146
20170112924
2017-04-27

Synthetic derivatives of MPL and uses thereof

 #147
20170112922
2017-04-27

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

 #148
20170112917
2017-04-27

PEPTIDE SCAFFOLD DESIGN

 #149
20170106081
2017-04-20

Cellular vaccine and method of inducing an immune response in a subject

 #150
20170072047
2017-03-16

Composition for Treating HBV Infection

 #151
20170065711
2017-03-09

Attenuated recombinant vesicular stomatitis virus vaccine vectors comprising modified matrix proteins

 #152
20170058003
2017-03-02

IMMUNOGEN PLATFORM

 #153
20170043011
2017-02-16

Synthetic hepatitis C polypeptide and methods of making and using same

 #154
20170029470
2017-02-02

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #155
20170015713
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

 #156
20170014506
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

 #157
20170000879
2017-01-05

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #158
20160361410
2016-12-15

MHC class I associated peptides for prevention and treatment of hepatitis B virus infection

 #159
20160324954
2016-11-10

IMMUNOGENIC COMPOSITIONS FOR INHIBITING HEPATITIS D VIRUS

 #160
20160310590
2016-10-27

ADJUVANT COMPOSITIONS

 #161
20160279236
2016-09-29

USE OF RAPAMYCIN AS VACCINE ADJUVANT AND PREPARATION METHOD THEREFOR

 #162
20160229896
2016-08-11

Fusion proteins for use as immunogenic enhancers for inducing antigen-specific T cell responses

 #163
20160193327
2016-07-07

Mucosal vaccine composition

 #164
20160193325
2016-07-07

INFECTIOUS HEPACIVIRUS PSEUDO-PARTICLES CONTAINING FUNCTIONAL e1, e2 ENVELOPE PROTEINS

 #165
20160185826
2016-06-30

VIRUS-LIKE PARTICLE VACCINES

 #166
20160158348
2016-06-09

Adjuvant combinations comprising alpha-galactosylceramide or iGb3, CD40 agonists and antigen

 #167
20160122312
2016-05-05

ANTI-VIRAL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

 #168
20160114030
2016-04-28

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #169
20160067332
2016-03-10

E1E2 HCV VACCINES AND METHODS OF USE

 #170
20160067331
2016-03-10

VIRAL PROTEINS AS IMMUNOMODULATORY AGENTS AND VACCINE COMPONENTS

 #171
20160051665
2016-02-25

INDUCTION OF IMMUNE RESPONSE

 #172
20160039883
2016-02-11

PALIVIZUMAB EPITOPE-BASED VIRUS-LIKE PARTICLES

 #173
20160032410
2016-02-04

Detection and use of antiviral resistance mutations

 #174
20160030361
2016-02-04

Cholestosome vesicles for incorporation of molecules into chylomicrons

 #175
20160024186
2016-01-28

Biological therapeutics for infection-relating disorders or conditions

 #176
20160015804
2016-01-21

Vaccine combinations

 #177
20160008459
2016-01-14

Immunogenic polypeptide surface layer-expressing bifidobacterium

 #178
20160000904
2016-01-07

IMPROVED POXVIRAL VACCINES

 #179
20150361132
2015-12-17

Macrocyclic inhibitors of viruses

 #180
20150359871
2015-12-17

Immunogenic compositions comprising silicified virus and methods of use

 #181
20150343089
2015-12-03

Hepatitis C virus liposome vaccine

 #182
20150329598
2015-11-19

Stabilized hepatitis B core polypeptides

 #183
20150328308
2015-11-19

Means for Eliciting an Immune Response and a Method Transfer

 #184
20150307558
2015-10-29

Chimeric vaccine antigens against hepatitis C virus

 #185
20150297645
2015-10-22

Cyclic di-AMP induction of type I interferon

 #186
20150291684
2015-10-15

Hepatitis C virus neutralizing antibodies and methods

 #187
20150274774
2015-10-01

Macrocyclic inhibitors of flaviviridae viruses

 #188
20150265701
2015-09-24

Immunomodulating compositions and uses therefor

 #189
20150258189
2015-09-17

HEPATITIS C VIRUS PARTICLES FORMATION PROMOTER, AND METHOD OF PRODUCING HEPATITIS C VIRUS PARTICLES

 #190
20150252084
2015-09-10

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #191
20150238630
2015-08-27

Compositions and methods for antigen targeting to CD180

 #192
20150216966
2015-08-06

Cellular vaccine and method of inducing an immune response in a subject

 #193
20150191509
2015-07-09

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #194
20150166612
2015-06-18

Vaccines and methods for using the same

 #195
20150140103
2015-05-21

Isolated nucleic acid for the production of a vaccine against virus

 #196
20150118319
2015-04-30

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

 #197
20150118264
2015-04-30

PHARMACEUTICAL COMPOSITION COMPRISING A POLYMERIC CARRIER CARGO COMPLEX AND AT LEAST ONE PROTEIN OR PEPTIDE ANTIGEN

 #198
20150110828
2015-04-23

Yeast-based therapeutic for chronic hepatitis B infection

 #199
20150050317
2015-02-19

Means for Eliciting an Immune Response and a Method Therefor

 #200
20150017207
2015-01-15

Methods and compositions for activation of innate immune responses through RIG-I like receptor signaling

 #201
20150017197
2015-01-15

HCV vaccines and methods for using the same

 #202
20150010595
2015-01-08

VACCINES COMPRISING AN IMMUNOSTIMULATORY PEPTIDE AND AN IMMUNOSTIMULATORY OLIGODEOXYNUCLEIC ACID MOLECULE

 #203
20140370049
2014-12-18

Method for formulating a vaccine containing at least two antigens capable of adsorbing onto aluminium oxyhydroxide

 #204
20140348906
2014-11-27

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #205
20140348866
2014-11-27

Method of inducing a cross-reactive HIV-1 immune response by administering a composition comprising the GBV-C E2 protein

 #206
20140341982
2014-11-20

Vaccination with immuno-isolated cells producing an immunomodulator

 #207
20140335110
2014-11-13

Laser-based vaccine adjuvants

 #208
20140328876
2014-11-06

SYNTHETIC DERIVATIVES OF MPL AND USES THEREOF

 #209
20140302087
2014-10-09

MANUFACTURE OF VACCINES THAT CONTAIN BOTH HEPATITIS B VIRUS SURFACE ANTIGEN AND SURFACTANT

 #210
20140286984
2014-09-25

Compositions and methods for the treatment or prevention of hepatitis B virus infection

 #211
20140234368
2014-08-21

Hypo- and hyper-acetylated meningococcal capsular saccharides

 #212
20140199763
2014-07-17

Compositions and methods to immunize against hepatitis C virus

 #213
20140193458
2014-07-10

Method of vaccination comprising a histone deacetylase inhibitor

 #214
20140193362
2014-07-10

Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection

 #215
20140162340
2014-06-12

Synthetic hepatitis C genome and methods of making and use

 #216
20140161826
2014-06-12

NON-SELF T-CELL EPITOPE FUSED TO AN ANTIBODY THAT RECOGNISES A TUMOUR-SPECIFIC CELL-SURFACE RECEPTOR AND USES THEREOF

 #217
20140120127
2014-05-01

Recombinant HCV E2 glycoprotein

 #218
20140105992
2014-04-17

Vaccine

 #219
20140065182
2014-03-06

Yeast-based therapeutic for chronic hepatitis B infection

 #220
20140056943
2014-02-27

IMMUNO-STIMULANT COMBINATION FOR PROPHYLAXIS AND TREATMENT OF HEPATITIS C

 #221
20140023683
2014-01-23

IDENTIFICATION OF TRANSMITTED HEPATITIS C VIRUS (HCV) GENOMES BY SINGLE GENOME AMPLIFICATION

 #222
20140004150
2014-01-02

Vaccine injection, preparation method and use thereof

 #223
20130344030
2013-12-26

Macrocyclic inhibitors of viruses

 #224
20130344029
2013-12-26

Macrocyclic inhibitors of flaviviridae viruses

 #225
20130337002
2013-12-19

Peptide scaffold design

 #226
20130337001
2013-12-19

Immunogenic composition for treatment of hepatitis C, a method for preparing the composition and use thereof for treating hepatitis C

 #227
20130323282
2013-12-05

Compositions and methods

 #228
20130323278
2013-12-05

Chimeric Flavivirus Vaccines

 #229
20130315945
2013-11-28

YEAST-BASED VACCINES AS IMMUNOTHERAPY

 #230
20130309265
2013-11-21

Yeast-based therapeutic for chronic hepatitis C infection

 #231
20130280298
2013-10-24

Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof

 #232
20130273101
2013-10-17

Vaccine for inducing an improved immune reaction

 #233
20130209395
2013-08-15

Nucleic acid molecule encoding hepatitis B virus core protein and surface antigen protein and vaccine comprising the same

 #234
20130202554
2013-08-08

COMPOSITIONS AND METHODS THAT ENHANCE AN IMMUNE RESPONSE

 #235
20130195923
2013-08-01

Microemulsions with adsorbed macromolecules and microparticles

 #236
20130195914
2013-08-01

Expression Of Positive Sense Single Stranded RNA Virus And Uses Thereof

 #237
20130195910
2013-08-01

Vaccine delivery method

 #238
20130183376
2013-07-18

HEPATITIS C VIRUS LIPOSOME VACCINE

 #239
20130171103
2013-07-04

METHODS FOR TREATING VIRAL CONDITIONS

 #240
20130089569
2013-04-11

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

 #241
20130084301
2013-04-04

Cluster of Neutralizing Antibodies to Hepatitis C Virus

 #242
20130078277
2013-03-28

Infectious hepatitis C virus—high producing HCV variants and use thereof

 #243
20130071422
2013-03-21

ADJUVANTED VACCINES FOR SEROGROUP B MENINGOCOCCUS

 #244
20130071421
2013-03-21

TURKEY VIRAL HEPATITIS VIRUS AND USES THEREOF

 #245
20130071420
2013-03-21

YEAST-BASED VACCINES AS IMMUNOTHERAPY

 #246
20130058969
2013-03-07

Chloroplasts engineered to express pharmaceutical proteins

 #247
20130045205
2013-02-21

Methods and compositions related to glycoprotein-immunoglobulin fusions

 #248
20130011435
2013-01-10

Composition for treating HBV infection

 #249
20120321659
2012-12-20

HBV CORE ANTIGEN PARTICLES WITH MULTIPLE IMMUNOGENIC COMPONENTS ATTACHED VIA PEPTIDE LIGANDS

 #250
20120301494
2012-11-29

Proteolysis-resistant capsid of chimeric hepatitis E virus as an oral delivery vector

 #251
20120301465
2012-11-29

COMPOSITIONS AND METHODS TO IMMUNIZE AGAINST HEPATITIS C VIRUS

 #252
20120288510
2012-11-15

Human antibodies against hepatitis C virus (HCV) and uses thereof

 #253
20120251572
2012-10-04

HEPATITIS C VIRUS VACCINE COMPOSITION

 #254
20120208870
2012-08-16

HEPATITIS C VIRUS CODON OPTIMIZED NON-STRUCTURAL NS3/4A FUSION GENE

 #255
20120207780
2012-08-16

Vaccine composition

 #256
20120201846
2012-08-09

POLYMER PARTICLES AND USES THEREOF

 #257
20120164107
2012-06-28

Cyclic di-AMP induction of type I interferon

 #258
20120156240
2012-06-21

Methods for preparing vesicles and formulations produced therefrom

 #259
20120135029
2012-05-31

Method for the purification of protein complexes

 #260
20120121537
2012-05-17

Methods and Compositions for Inhibiting Hepatitis C Virus Replication

 #261
20120114746
2012-05-10

Immunostimulatory compositions comprising liposome-encapsulated oligonucleotides and epitopes

 #262
20120107345
2012-05-03

Manufacture of vaccines that contain both hepatitis B virus surface antigens and surfactant

 #263
20120100170
2012-04-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C

 #264
20120093863
2012-04-19

HCV vaccines and methods for using the same

 #265
20120087946
2012-04-12

Recombinant bacterium and methods of antigen and nucleic acid delivery

 #266
20120064169
2012-03-15

Multiple antigen delivery system using hepatitis E virus-like particle

 #267
20120040367
2012-02-16

CONSTRUCT SYSTEM AND USES THEREFOR

 #268
20120039842
2012-02-16

Compositions and methods that enhance an immune response

 #269
20120034256
2012-02-09

HCV vaccines and methods for using the same

 #270
20120027795
2012-02-02

SIMPLE VACCINES FROM DNA LAUNCHED SUICIDAL FLAVIVIRUSES

 #271
20120010394
2012-01-12

Immunogen platform

 #272
20120003719
2012-01-05

Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)

 #273
20110311573
2011-12-22

Method for preparing recombinant antigen complex using rotavirus nanoparticle

 #274
20110300170
2011-12-08

HCV VACCINES

 #275
20110300169
2011-12-08

Pharmaceutical composition comprising an antigen

 #276
20110293656
2011-12-01

RECOMBINANT MVA CAPABLE OF EXPRESSING STRUCTURAL HCV ANTIGENS

 #277
20110280899
2011-11-17

Immunogenic lipopeptides comprising T-helper and cytotoxic T-lymphocyte (CTL) epitopes

 #278
20110275139
2011-11-10

Recombinant vaccinia virus having hepatitis C virus gene

 #279
20110274719
2011-11-10

Helicobacter system and uses thereof

 #280
20110256098
2011-10-20

Immunotherapy for chronic hepatitis C virus infection

 #281
20110223185
2011-09-15

CHIMERIC HEPATITIS C VIRUS ANTIGENS FOR ELICITING AN IMMUNE RESPONSE

 #282
20110212124
2011-09-01

Vaccine Composition

 #283
20110206711
2011-08-25

METHOD FOR INDUCING CYTOTOXIC T-CELLS, CYTOTOXIC T-CELL INDUCER, AND PHARMACEUTICAL COMPOSITION AND VACCINE EMPLOYING SAME

 #284
20110177163
2011-07-21

COMPOSITIONS AND METHODS FOR TREATING HEPATITIS A

 #285
20110177110
2011-07-21

COMPOSITIONS COMPRISING CATIONIC MICROPARTICLES AND HCV E1E2 DNA AND METHODS OF USE THEREOF

 #286
20110159039
2011-06-30

ELICITING HCV-SPECIFIC ANTIBODIES

 #287
20110150921
2011-06-23

Fusion proteins and use thereof for preparing hepatitis C vaccines

 #288
20110150909
2011-06-23

Yeast-based vaccines as immunotherapy

 #289
20110129489
2011-06-02

METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR

 #290
20110110974
2011-05-12

METHODS AND KITS FOR INDUCING A CTL RESPONSE USING A PRIME BOOST REGIMEN

 #291
20110091495
2011-04-21

HCV E2 CONSTRUCT COMPOSITIONS AND METHODS

 #292
20110082287
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #293
20110081381
2011-04-07

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #294
20110076304
2011-03-31

ADAPTER MOLECULE FOR THE DELIVERY OF ADENOVIRUS VECTORS

 #295
20110065174
2011-03-17

Hepatitis C virus codon optimized non-structural NS3/4A fusion gene

 #296
20110059513
2011-03-10

Efficient cell culture system for hepatitis C virus genotype 1A and 1B

 #297
20110059512
2011-03-10

Efficient cell culture system for hepatitis C virus genotype 6A

 #298
20110059132
2011-03-10

COMPOSITION FOR THERAPY AND/OR FOR PROPHYLAXIS OF HBV-INFECTIONS AND HBV-MEDIATED DISEASES

 #299
20110059116
2011-03-10

LASER-BASED VACCINE ADJUVANTS

 #300
20110045020
2011-02-24

Nucleic acid comprising chimeric gene derived from hepatitis C virus